| Market Size in 2025 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 1.5 Billion | USD 5.32 Billion | 15.10% | 2025 |
FrequentlyAsked Questions
Health Economics and Outcomes Research (HEOR) is a research approach that evaluates the clinical, economic, and real-world value of medicines, medical devices, and healthcare treatments. It helps healthcare companies, governments, insurers, and hospitals understand whether a treatment improves patient health while providing good value for its cost.
The global HEOR services market is expected to grow due to rising drug development costs, stricter payer reimbursement requirements, growing availability of real-world data, and increasing government demand for proof of treatment value before providing coverage.
According to research, the global HEOR services market was valued at approximately USD 1.5 billion in 2025 and is projected to reach approximately USD 5.32 billion by 2034.
The compound annual growth rate of the HEOR services market is expected to be approximately 15.10% from 2026 to 2034.
North America is expected to lead the global HEOR services market throughout the forecast period, driven by its complex reimbursement system, strong pharmaceutical industry presence, and well-established demand for economic evidence from insurers and regulators.
The major players in the global HEOR services market include IQVIA, ICON plc, Parexel International, Evidera, RTI Health Solutions, PPD Incorporated, Syneos Health, Certara, Optum Life Sciences, and Genesis Research Group.
The report examines key aspects of the HEOR services market, including growth drivers, adoption barriers, therapeutic application opportunities, competitive landscape dynamics, detailed regional market performance analysis, and a comprehensive forward-looking outlook across all major service types, therapeutic areas, end user segments, service providers, and geographic regions through 2034.
The HEOR services market offers strong investment opportunities in real-world evidence, artificial intelligence-driven analytics, digital health data platforms, and value-based healthcare solutions. Partnerships between pharmaceutical companies, contract research organizations, technology providers, and healthcare institutions are expanding to improve evidence generation and market access.
The HEOR services market is highly competitive, with global contract research organizations, consulting firms, data analytics companies, and specialized HEOR providers competing through advanced analytics, real-world evidence capabilities, regulatory expertise, strategic partnerships, and comprehensive end-to-end research services.
The HEOR services market is being shaped by artificial intelligence, machine learning, real-world evidence, predictive analytics, patient-reported outcomes, and digital health data integration. These innovations are improving evidence generation, accelerating reimbursement decisions, and supporting value-based healthcare worldwide.
HappyClients